Evidence map›Paper›PMID 30267149›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2019

Neurobiology of the major psychoses: a translational perspective on brain structure and function-the FOR2107 consortium.

Tilo Kircher, Markus Wöhr, Igor Nenadic, Rainer Schwarting, Gerhard Schratt, Judith Alferink, Carsten Culmsee, Holger Garn, Tim Hahn, Bertram Müller-Myhsok and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 4 pooled it
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 4 syntheses or guidelines pooled it, 174 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. The neuroanatomy of depression: weak but replicable effects in 4021 individuals from three clinical cohorts.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  8. Article
  9. Article
  10. Observational
  11. Observational
  12. Article
  13. Network-based analysis of differential white matter connectivity in major depressive disorder with and without comorbid anxiety.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Tilo KircherDepartment of Psychiatry and Psychotherapy, University of Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany. kircher2@staff.uni-marburg.de.ORCID http://orcid.org/0000-0002-2514-2625
Markus WöhrCentre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany.
Igor NenadicDepartment of Psychiatry and Psychotherapy, University of Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
Rainer SchwartingCentre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany.
Gerhard SchrattDepartment of Neuroscience, ETH Zürich, Zurich, Germany.
Judith AlferinkDepartment of Psychiatry and Psychotherapy, University of Münster, Munich, Germany.
Carsten CulmseeCentre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany.
Holger GarnInstitute of Laboratory Medicine and Pathobiochemistry, University of Marburg, Marburg, Germany.
Tim HahnDepartment of Psychiatry and Psychotherapy, University of Münster, Munich, Germany.
Bertram Müller-MyhsokMax Planck Institute of Psychiatry, Munich, Germany.
Astrid DempfleInstitute of Medical Informatics and Statistics, University of Kiel, Kiel, Germany.
Maik HahmannCoordinating Centre for Clinical Trials, University of Marburg, Marburg, Germany.
Andreas JansenDepartment of Psychiatry and Psychotherapy, University of Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
Petra PfefferleComprehensive Biomaterial Bank Marburg, University of Marburg, Marburg, Germany.
Harald RenzInstitute of Laboratory Medicine and Pathobiochemistry, University of Marburg, Marburg, Germany.
Marcella RietschelDepartment of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
Stephanie H WittDepartment of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
Markus NöthenDepartment of Genomics, Life and Brain Centre, University of Bonn, Bonn, Germany.
Axel KrugDepartment of Psychiatry and Psychotherapy, University of Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
Udo DannlowskiDepartment of Psychiatry and Psychotherapy, University of Münster, Munich, Germany.
Philipps University of Marburg · DEUniversity of Münster · DEHeidelberg University · DEChristian-Albrechts-Universität zu Kiel · DEMax Planck Institute of Psychiatry · DEUniversity of Bonn · DE

Funding

Deutsche Forschungsgemeinschaft AL 1145/5-2Deutsche Forschungsgemeinschaft CU 43/9-1Deutsche Forschungsgemeinschaft CU 43/9-2Deutsche Forschungsgemeinschaft DA 1151/5-1Deutsche Forschungsgemeinschaft DA 1151/5-2Deutsche Forschungsgemeinschaft DE 1614/3-2Deutsche Forschungsgemeinschaft GA 545/7-2Deutsche Forschungsgemeinschaft HA 7070/2-2Deutsche Forschungsgemeinschaft JA 1890/7-1Deutsche Forschungsgemeinschaft JA 1890/7-2Deutsche Forschungsgemeinschaft KI 588/14-1Deutsche Forschungsgemeinschaft KI 588/14-2Deutsche Forschungsgemeinschaft KI 588/17-1Deutsche Forschungsgemeinschaft KR 3822/7-1Deutsche Forschungsgemeinschaft KR 3822/7-2Deutsche Forschungsgemeinschaft MU 1315/8-2Deutsche Forschungsgemeinschaft NE 2254/1-2Deutsche Forschungsgemeinschaft NO 246/10-2Deutsche Forschungsgemeinschaft PF 784/1-2Deutsche Forschungsgemeinschaft RE 737/20-2Deutsche Forschungsgemeinschaft RI 908/11-2Deutsche Forschungsgemeinschaft SCHW 559/14-1Deutsche Forschungsgemeinschaft SCHW 559/14-2Deutsche Forschungsgemeinschaft WI 3439/3-2Deutsche Forschungsgemeinschaft WO 1732/4-1Deutsche Forschungsgemeinschaft WO 1732/4-2
6 · The paper itself

Abstract

Genetic (G) and environmental (E) factors are involved in the etiology and course of the major psychoses (MP), i.e. major depressive disorder (MDD), bipolar disorder (BD), schizoaffective disorder (SZA) and schizophrenia (SZ). The neurobiological correlates by which these predispositions exert their influence on brain structure, function and course of illness are poorly understood. In the FOR2107 consortium, animal models and humans are investigated. A human cohort of MP patients, healthy subjects at genetic and/or environmental risk, and control subjects (N = 2500) has been established. Participants are followed up after 2 years and twice underwent extensive deep phenotyping (MR imaging, clinical course, neuropsychology, personality, risk/protective factors, biomaterials: blood, stool, urine, hair, saliva). Methods for data reduction, quality assurance for longitudinal MRI data, and (deep) machine learning techniques are employed. In the parallelised animal cluster, genetic risk was introduced by a rodent model (Cacna1c deficiency) and its interactions with environmental risk and protective factors are studied. The animals are deeply phenotyped regarding cognition, emotion, and social function, paralleling the variables assessed in humans. A set of innovative experimental projects connect and integrate data from the human and animal parts, investigating the role of microRNA, neuroplasticity, immune signatures, (epi-)genetics and gene expression. Biomaterial from humans and animals are analyzed in parallel. The FOR2107 consortium will delineate pathophysiological entities with common neurobiological underpinnings ("biotypes") and pave the way for an etiologic understanding of the MP, potentially leading to their prevention, the prediction of individual disease courses, and novel therapies in the future.

Indexed as

AnimalsBrainCalcium Channels, L-TypeCase-Control StudiesDisease Models, AnimalFemaleGenetic Predisposition to DiseaseHumansInterview, PsychologicalMagnetic Resonance ImagingMaleMicroRNAsNeuroimagingPhenotypePsychotic DisordersRatsCacna1c protein, ratCalcium Channels, L-TypeMicroRNAsAnimal modelCohort studyCourse of illnessEtiologyMental disorder

Identifiers

PMID30267149
OpenAlexW2893665966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.